Loading...
Market
What key leadership changes will occur at Lykos Therapeutics by December 31, 2025?
2
Lykos Therapeutics•Antonio Gracias•Tesla•Gracias•Maps•Rick Doblin•Jeff Aronin•Paragon Biosciences•Lykos•FDA•Helena
Resolution / Starting Odds
CEO change • 25%
Board reshuffle • 25%
No significant changes • 25%
Other leadership changes • 25%
Official announcements from Lykos Therapeutics
Story
Antonio Gracias Leads Hostile Takeover Bid for MDMA Startup Lykos Therapeutics, Backed by $100 Million Funding and Rick Doblin
Jan 10, 2025, 05:38 AM
Lykos Therapeutics, a startup focused on MDMA-based therapies, is facing a hostile takeover bid led by Antonio Gracias, an early investor in Tesla. Gracias, who is allied with Maps founder Rick Doblin, aims to secure a controlling stake in the company with the support of Jeff Aronin, a prominent figure in the pharmaceutical industry and founder of Paragon Biosciences. The bid comes amid ongoing challenges for Lykos, including issues related to sexual abuse by therapists during clinical trials, which were highlighted during a recent FDA review. Additionally, Helena, which spearheaded Lykos's $100 million funding round last year, is reportedly seeking to sever ties between Lykos and the non-profit organization Maps, holding veto rights over any potential deal.
View original story
Similar markets
CEO change • 25%
Other leadership change • 25%
No change • 25%
Board restructuring • 25%
CFO change • 25%
CEO change • 25%
No major changes • 25%
Both CEO and CFO change • 25%
No change • 25%
Both CEO and CFO change • 25%
CFO change • 25%
CEO change • 25%
No changes • 25%
COO change • 25%
CISO change • 25%
CEO change • 25%
New CEO • 25%
No change • 25%
New CFO • 25%
New CEO and CFO • 25%
New CEO appointed • 25%
No changes in top leadership • 25%
Other executive changes • 25%
New CFO appointed • 25%
Al-Jolani replaced • 25%
Leadership structure changes • 25%
No significant leadership changes • 25%
Al-Jolani remains leader • 25%
BLA Disbands • 25%
New Leader Announced • 25%
Leadership Dispute • 25%
No Change in Leadership • 25%
Restructuring of executive team • 25%
No changes • 25%
Nunes remains CEO • 25%
New CEO appointed • 25%
None • 25%
CEO • 25%
CTO • 25%
CFO • 25%
Other executive changes • 25%
No major changes • 25%
Elon Musk steps down as CEO • 25%
New CFO appointed • 25%